Marker Therapeutics, Inc. (MRKR)
1.38
-0.01
(-0.72%)
USD |
NASDAQ |
Mar 06, 16:00
1.38
0.00 (0.00%)
After-Hours: 20:00
Marker Therapeutics Revenue (TTM) : 4.695M for Sept. 30, 2025
Revenue (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Revenue (TTM) Benchmarks
| ADMA Biologics, Inc. | 510.17M |
| Viridian Therapeutics, Inc. | 70.85M |
| ACADIA Pharmaceuticals, Inc. | 1.072B |
| Kiniksa Pharmaceuticals International Plc | 677.56M |
| Neurocrine Biosciences, Inc. | 2.860B |